Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

Stock Information for Verrica Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Verrica Pharmaceuticals Inc.

Attention Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA): a Securities Fraud Class Action Has Survived a Motion to Dismiss
Attention Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA): a Securities Fraud Class Action Has Survived a Motion to Dismiss
VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
Notice to Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA): Grabar Law Office Investigates Claims on Your Behalf
Notice to Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA)
VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
SHAREHOLDER ALERT: Morris Kandinov Investigating SHLS, VRCA, IRTC and NSSC; Shareholders are Encouraged to Contact the Firm
Grabar Law Office Investigates Claims on Behalf of Shareholders of Verrica Pharmaceuticals, Inc. (VRCA) After Securities Fraud Class Action Survives Motion to Dismiss

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.